[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wu et al., 2018 - Google Patents

Gadolinium-chelate functionalized bismuth nanotheranostic agent for in vivo MRI/CT/PAI imaging-guided photothermal cancer therapy

Wu et al., 2018

View PDF
Document ID
15803018955522995719
Author
Wu B
Lu S
Yu H
Liao R
Li H
Zafitatsimo B
Li Y
Zhang Y
Zhu X
Liu H
Xu H
Huang S
Cheng Z
Publication year
Publication venue
Biomaterials

External Links

Snippet

Multifunctional nanomaterials with simple structure and good biosafety, integrating multimodal imaging and therapeutic functions, can facilitate the development of clinical cancer treatments. Here, a simple but powerful pure bismuth based nanoparticle (Gd-PEG …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb

Similar Documents

Publication Publication Date Title
Wu et al. Gadolinium-chelate functionalized bismuth nanotheranostic agent for in vivo MRI/CT/PAI imaging-guided photothermal cancer therapy
Sun et al. An intelligent nanoplatform for simultaneously controlled chemo-, photothermal, and photodynamic therapies mediated by a single NIR light
Deng et al. Functionalization of small black phosphorus nanoparticles for targeted imaging and photothermal therapy of cancer
Wang et al. Oxygen-supplementing mesoporous polydopamine nanosponges with WS2 QDs-embedded for CT/MSOT/MR imaging and thermoradiotherapy of hypoxic cancer
Zhang et al. Renal-clearable ultrasmall covalent organic framework nanodots as photodynamic agents for effective cancer therapy
Cheng et al. PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy
Wang et al. Self-assembled zinc phthalocyanine nanoparticles as excellent photothermal/photodynamic synergistic agent for antitumor treatment
Zhou et al. NIR photothermal therapy using polyaniline nanoparticles
Zhou et al. Water-dispersible Prussian blue hyaluronic acid nanocubes with near-infrared photoinduced singlet oxygen production and photothermal activities for cancer theranostics
Chen et al. Ultrahigh 19F loaded Cu1. 75S nanoprobes for simultaneous 19F magnetic resonance imaging and photothermal therapy
Su et al. Cetuximab-conjugated iodine doped carbon dots as a dual fluorescent/CT probe for targeted imaging of lung cancer cells
Zhou et al. Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy
Zhang et al. Graphene oxide-BaGdF5 nanocomposites for multi-modal imaging and photothermal therapy
Zhang et al. Self-quenched metal–organic particles as dual-mode therapeutic agents for photoacoustic imaging-guided second near-infrared window photochemotherapy
Liao et al. Innovative ligand-assisted synthesis of NIR-activated iron oxide for cancer theranostics
Zou et al. Design and synthesis of a lead sulfide based nanotheranostic agent for computer tomography/magnetic resonance dual-mode-bioimaging-guided photothermal therapy
Liu et al. Highly stable molybdenum dioxide nanoparticles with strong plasmon resonance are promising in photothermal cancer therapy
Liu et al. Manganese (II) chelate functionalized copper sulfide nanoparticles for efficient magnetic resonance/photoacoustic dual-modal imaging guided photothermal therapy
Liu et al. Fluorescence-enhanced covalent organic framework nanosystem for tumor imaging and photothermal therapy
Zhang et al. Peroxidase-like Fe 3 O 4 nanocomposite for activatable reactive oxygen species generation and cancer theranostics
Bai et al. Multifunctional magnetic-hollow gold nanospheres for bimodal cancer cell imaging and photothermal therapy
Chen et al. Facile synthesis of novel albumin-functionalized flower-like MoS 2 nanoparticles for in vitro chemo-photothermal synergistic therapy
Zhang et al. Multifunctional oxygen-enriching nano-theranostics for cancer-specific magnetic resonance imaging and enhanced photodynamic/photothermal therapy
Bi et al. Doxorubicin-conjugated CuS nanoparticles for efficient synergistic therapy triggered by near-infrared light
Liu et al. Gold nanostars decorated MnO2 nanosheets for magnetic resonance imaging and photothermal erasion of lung cancer cell